Management of Metastatic Melanoma
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 34 (6) , 532-545
- https://doi.org/10.1053/j.seminoncol.2007.09.008
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Sequential Biochemotherapy Versus Chemotherapy for Metastatic Melanoma: Results From a Phase III Randomized TrialJournal of Clinical Oncology, 2002
- Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical TrialJournal of Clinical Oncology, 2002
- Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm studyMelanoma Research, 2002
- Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trialBritish Journal of Cancer, 2001
- Phase III Clinical Trial of the Combination of Cisplatin, Dacarbazine, and Carmustine With or Without Tamoxifen in Patients With Advanced Malignant MelanomaJournal of Clinical Oncology, 1999
- A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanomaCancer, 1999
- Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trialEuropean Journal Of Cancer, 1998
- Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosoureaCancer, 1972
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanomaClinical Pharmacology & Therapeutics, 1971